These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1834600)

  • 1. Long-term changes of striatal D-2 receptors in rats chronically exposed to morphine under aversive life conditions.
    Kiyatkin EA; Belyi VP; Rusakov DYu ; Maksimov VV; Pankratova NV; Rozhanets VV
    Int J Neurosci; 1991 May; 58(1-2):55-61. PubMed ID: 1834600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of [3H]spiroperidol to striatal membranes of rats treated chronically with morphine. Influence of Pro-Leu-Gly-NH2 and cyclo(Leu-Gly).
    Bhargava HN
    Neuropharmacology; 1983 Dec; 22(12A):1357-61. PubMed ID: 6141535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reinforcing properties of morphine chronically used in aversive life conditions: place-preference paradigm, long-term changes in behavioral reactivity.
    Kiyatkin EA; Belyi VP
    Int J Neurosci; 1991 Apr; 57(3-4):193-203. PubMed ID: 1938162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclo (Leu-Gly) attenuates the striatal dopaminergic supersensitivity induced by chronic morphine.
    Lee JM; DeLeon-Jones F; Fields JZ; Ritzmann RF
    Alcohol Drug Res; 1987; 7(1):1-10. PubMed ID: 2431697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cataleptogenic doses of morphine suppress 3H-spiroperidol binding to striatal membranes.
    Golembiowska-Nikitin K; Pilc A; Vetulani J
    Naunyn Schmiedebergs Arch Pharmacol; 1982 May; 319(2):140-1. PubMed ID: 7202125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively.
    Urwyler S; Markstein R
    J Neurochem; 1986 Apr; 46(4):1058-67. PubMed ID: 2936868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of morphine-induced changes in striatal (3H)-spiroperidol binding and stereotype-behavior by cyclo(Leu-Gly).
    Ritzmann RF; Lee JM; Fields JZ
    Life Sci; 1982 May; 30(18):1573-80. PubMed ID: 7200563
    [No Abstract]   [Full Text] [Related]  

  • 8. Dopamine receptor sensitivity after chronic dopamine agonists. Striatal 3H-spiroperidol binding in mice after chronic administration of high doses of apomorphine, N-n-propylnorapomorphine and dextroamphetamine.
    Riffee WH; Wilcox RE; Vaughn DM; Smith RV
    Psychopharmacology (Berl); 1982; 77(2):146-9. PubMed ID: 6812131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of opiates in striatal D-1 dopamine receptor supersensitivity induced by chronic L-dopa treatment.
    Groppetti A; Ceresoli G; Mandelli V; Parenti M
    J Pharmacol Exp Ther; 1990 Jun; 253(3):950-6. PubMed ID: 2162953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronically administered morphine increases dopamine receptor sensitivity in mice.
    Martin JR; Takemori AE
    Eur J Pharmacol; 1986 Feb; 121(2):221-9. PubMed ID: 3699094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide inhibition of morphine-induced dopaminergic supersensitivity.
    Ritzmann RF; Lee JM; Fields JZ
    Life Sci; 1982 Nov 15-22; 31(20-21):2287-90. PubMed ID: 6891737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnesium ions reveal nanomolar potency of dopamine at [3H]spiperone labelled D-2 receptors in rat corpus striatum.
    De Vries DJ; Beart PM
    Eur J Pharmacol; 1985 Mar; 109(3):417-9. PubMed ID: 3157589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol.
    Hancock AA; Marsh CL
    Mol Pharmacol; 1984 Nov; 26(3):439-51. PubMed ID: 6238230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
    Thomas KL; Rose S; Jenner P; Marsden CD
    Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic haloperidol does not alter agonist affinity for dopamine receptors in vitro.
    Meller E; Bohmaker K; Goldstein M; Schweitzer JW; Friedhoff AJ
    Eur J Pharmacol; 1985 Mar; 109(3):389-94. PubMed ID: 3157587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of 3H-spiperone and 3H-(-)-sulpiride to dopamine D2 receptors in rat striatal membranes: methodological considerations and demonstration of the identical nature of the binding sites for the two ligands.
    Urwyler S; Coward D
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Feb; 335(2):115-22. PubMed ID: 2951601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclo(Leu-Gly) attenuates the striatal dopaminergic supersensitivity induced by chronic morphine: agonist binding to D2 dopamine receptors correlates with stereotypic behavior.
    Lee JM; Fields JZ; Ritzmann RF
    Life Sci; 1983; 33 Suppl 1():405-8. PubMed ID: 6229678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of estrogens on striatal dopaminergic activity.
    Ramos JA; Pais JR; Cebeira M; Fernandez-Ruiz J
    J Steroid Biochem; 1987; 27(4-6):683-9. PubMed ID: 2961941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral decortication reverses the effect of amphetamine on striatal D2 dopamine binding site density.
    Robertson HA
    Neurosci Lett; 1986 Dec; 72(3):325-9. PubMed ID: 2950342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MIF-1 attenuates spiroperidol alteration of striatal dopamine D2 receptor ontogeny.
    Saleh MI; Kostrzewa RM
    Peptides; 1989; 10(1):35-9. PubMed ID: 2568624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.